Literature DB >> 11029283

Overexpression of fructose 2,6-bisphosphatase decreases glycolysis and delays cell cycle progression.

J X Perez1, T Roig, A Manzano, M Dalmau, J Boada, F Ventura, J L Rosa, J Bermudez, R Bartrons.   

Abstract

The ability to overexpress 6-phosphofructo-2-kinase/fructose 2, 6-bisphosphatase (PFK-2)/(FBPase-2) or a truncated form of the enzyme with only the bisphosphatase domain allowed us to analyze the relative role of the kinase and the bisphosphatase activities in regulating fructose 2,6-bisphosphate (Fru-2,6-P(2)) concentration and to elucidate their differential metabolic impact in epithelial Mv1Lu cells. The effect of overexpressing PFK-2/FBPase-2 resulted in a small increase in the kinase activity and in the activity ratio of the bifunctional enzyme, increasing Fru-2,6-P(2) levels, but these changes had no major effects on cell metabolism. In contrast, expression of the bisphosphatase domain increased the bisphosphatase activity, producing a significant decrease in Fru-2,6-P(2) concentration. The fall in the bisphosphorylated metabolite correlated with a decrease in lactate production and ATP concentration, as well as a delay in cell cycle. These results provide support for Fru-2,6-P(2) as a regulator of glycolytic flux and point out the role of glycolysis in cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029283     DOI: 10.1152/ajpcell.2000.279.5.C1359

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  7 in total

1.  An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase.

Authors:  Silvia Fernández de Mattos; Eric W-F Lam; Albert Tauler
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

2.  Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.

Authors:  C M García-Herrero; M Galán; O Vincent; B Flández; M Gargallo; E Delgado-Alvarez; E Blázquez; M A Navas
Journal:  Diabetologia       Date:  2006-12-21       Impact factor: 10.122

3.  PFKFB3, a Direct Target of p63, Is Required for Proliferation and Inhibits Differentiation in Epidermal Keratinocytes.

Authors:  Robert B Hamanaka; Gökhan M Mutlu
Journal:  J Invest Dermatol       Date:  2017-01-17       Impact factor: 8.551

4.  Phosphofructo-2-kinase/fructose-2,6-bisphosphatase modulates oscillations of pancreatic islet metabolism.

Authors:  Matthew J Merrins; Richard Bertram; Arthur Sherman; Leslie S Satin
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

5.  Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question.

Authors:  Khalid O Alfarouk; Daniel Verduzco; Cyril Rauch; Abdel Khalig Muddathir; H H Bashir Adil; Gamal O Elhassan; Muntaser E Ibrahim; Julian David Polo Orozco; Rosa Angela Cardone; Stephan J Reshkin; Salvador Harguindey
Journal:  Oncoscience       Date:  2014-12-18

6.  Modulation of intracellular ROS levels by TIGAR controls autophagy.

Authors:  Karim Bensaad; Eric C Cheung; Karen H Vousden
Journal:  EMBO J       Date:  2009-08-27       Impact factor: 11.598

7.  6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27.

Authors:  A Yalcin; B F Clem; Y Imbert-Fernandez; S C Ozcan; S Peker; J O'Neal; A C Klarer; A L Clem; S Telang; J Chesney
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.